Followers | 241 |
Posts | 4868 |
Boards Moderated | 0 |
Alias Born | 08/15/2012 |
Friday, February 12, 2021 5:35:46 PM
Relax nothing to be personal lol
Good weekend
Recent ARTL News
- Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 01:00:00 PM
- Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 12:00:00 PM
- Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor • GlobeNewswire Inc. • 07/15/2024 12:30:00 PM
- Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium • GlobeNewswire Inc. • 07/03/2024 01:00:00 PM
- Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform • GlobeNewswire Inc. • 07/02/2024 01:00:00 PM
- Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium • GlobeNewswire Inc. • 07/01/2024 01:00:00 PM
- Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society • GlobeNewswire Inc. • 06/04/2024 12:30:00 PM
- Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24 • GlobeNewswire Inc. • 05/29/2024 12:30:00 PM
- Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th • GlobeNewswire Inc. • 05/10/2024 01:00:00 PM
- Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy • GlobeNewswire Inc. • 04/23/2024 12:30:00 PM
- Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time • GlobeNewswire Inc. • 04/22/2024 12:30:00 PM
- Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge • GlobeNewswire Inc. • 03/12/2024 01:15:00 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy • GlobeNewswire Inc. • 01/23/2024 01:30:00 PM
- Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12 • GlobeNewswire Inc. • 01/08/2024 01:30:00 PM
- Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany • GlobeNewswire Inc. • 12/05/2023 01:30:00 PM
- Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany • GlobeNewswire Inc. • 11/30/2023 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:02:44 PM
- Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers • GlobeNewswire Inc. • 11/09/2023 02:00:00 PM
- Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023 • GlobeNewswire Inc. • 11/02/2023 12:30:00 PM
- Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia • GlobeNewswire Inc. • 10/04/2023 12:30:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM